Study on bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride

Trial Profile

Study on bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Jun 2007

At a glance

  • Drugs Dutasteride; Testosterone
  • Indications Benign prostatic hyperplasia; Prostate cancer; Prostatic intraepithelial neoplasia
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 20 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top